SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000827871-22-000008
Filing Date
2022-03-08
Accepted
2022-03-07 18:10:20
Documents
88
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K egrx-20211231.htm   iXBRL 10-K 2570894
2 EX-21 exhibit21110k2021.htm EX-21 3418
3 EX-23.1 exhibit23110k2021.htm EX-23.1 3498
4 EX-23.2 exhibit232bdoconsent1.htm EX-23.2 2635
5 EX-31.1 exhibit31110k2021.htm EX-31.1 8952
6 EX-31.2 exhibit31210k2021.htm EX-31.2 8938
7 EX-32.1 exhibit32110k2021.htm EX-32.1 7452
13 egrx-20211231_g1.jpg GRAPHIC 145520
  Complete submission text file 0000827871-22-000008.txt   10613286

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT egrx-20211231.xsd EX-101.SCH 51434
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT egrx-20211231_cal.xml EX-101.CAL 126466
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT egrx-20211231_def.xml EX-101.DEF 238222
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT egrx-20211231_lab.xml EX-101.LAB 743975
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT egrx-20211231_pre.xml EX-101.PRE 487421
82 EXTRACTED XBRL INSTANCE DOCUMENT egrx-20211231_htm.xml XML 1847160
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36306 | Film No.: 22719649
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences